---  
layout: startup_page  
title: "Eikonizo Therapeutics"  
id: "eikonizo.com"  
permalink: "/eikonizotherapeuticseikonizo.com12102024/"  
website: "https://eikonizo.com/"  
funding_round: "Equity"  
funding_amount: ""  
investors: "Novo Nordisk"  
about: "Eikonizo Therapeutics is a biopharmaceutical company developing disease-modifying therapies for neurodegenerative and cardiorenal diseases. Their lead candidate, EKZ-102, is a first-in-class, oral HDAC6 inhibitor designed to protect neuronal function while minimizing side effects. The company aims to provide novel treatments targeting key drivers of these diseases."  
markets: "Biopharmaceuticals, Neurodegenerative Diseases, Cardiorenal Diseases"  
hq: "Cambridge, Massachusetts, United States"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/eikonizo-therapeutics"  
twitter: "https://twitter.com/Eikonizo"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/eikonizo-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/290435-41"  

date_display: "10-Dec-2024"  
date: "2024-12-10"

# SEO Optimization  
meta_title: "Eikonizo Therapeutics - Equity"  
meta_description: "Eikonizo Therapeutics, Eikonizo Therapeutics is a biopharmaceutical company developing disease-modifying therapies for neurodegenerative and cardiorenal diseases. Their lead..."  
meta_keywords: "Eikonizo Therapeutics, Biopharmaceuticals, Neurodegenerative Diseases, Cardiorenal Diseases, Equity funding"  
canonical_url: "https://startup.projectstartups.com/eikonizotherapeuticseikonizo.com12102024/"  
---